The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider 667, L.p. since year 2005.
The trader's CIK number is 1551139.
At the time of this reporting, 667, L.p. is the Director of Hybridon Inc .
(stock ticker symbol HBY).
See this page for all insider trading activities at Hybridon Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-01-29||MRTX||Mirati Therapeutics, Inc.||Buy||425,000||20.00||8,500,000|
|2012-11-13||GHDX||Genomic Health Inc||Buy||103,839||27.99||2,906,661|
|2012-11-12||GHDX||Genomic Health Inc||Buy||200,000||27.94||5,587,400|
|2012-11-09||GHDX||Genomic Health Inc||Buy||519,933||27.05||14,061,587|
|2012-11-14||GHDX||Genomic Health Inc||Buy||103,167||27.32||2,818,212|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by 667, L.p. (Director of Hybridon Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.